查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1448643

全球临床试验设备和辅助解决方案市场研究报告 - 2024 年至 2032 年行业分析、规模、份额、成长、趋势和预测

Global Clinical Trial Equipment & Ancillary Solutions Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 128 Pages | 商品交期: 最快1-2个工作天内

价格

全球临床试验设备和辅助解决方案市场需求预计将从 2023 年的 31 亿美元达到 2032 年近 70.2 亿美元的市场规模，2024-2032 年研究期间CAGR为 9.5%。

临床试验设备和辅助解决方案是指医学研究中用于收集资料和进行实验的工具、设备和支援服务。这包括从诊断设备到实验室仪器的各种设备，以及资料管理、物流和法规遵循支援等辅助服务。这些资源对于确保药物和医疗保健研究中临床试验的顺利、可靠执行至关重要。

市场动态

临床试验设备和辅助解决方案市场受到临床试验数量不断增加、医学研究进步以及慢性病盛行率上升等因素的推动。临床试验日益复杂，需要各种专业设备和辅助服务，包括资料管理工具、物流和实验室服务。对精准医疗和个人化治疗的重视进一步增加了对先进临床试验设备的需求。简化药物开发流程的监管支持和措施有助于市场成长。此外，合约研究组织（CRO）的扩张和临床试验的全球化推动了对综合设备和辅助解决方案的需求，推动了整体市场的发展。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球临床试验设备和辅助解决方案市场的各个细分市场进行了包容性评估。临床试验设备和辅助解决方案产业的成长和趋势为本研究提供了整体方法。

市场区隔

临床试验设备和辅助解决方案市场报告的这一部分提供了国家和地区层面细分市场的详细资料，从而帮助策略家确定相应产品或服务的目标人群以及即将到来的机会。

按产品分类

  • 采购（购买（设备、辅助设备）、租赁（设备、辅助设备））
  • 供应/物流（运输、包装、其他）
  • 服务（校准、设备维修、其他）
  • 其他的

按阶段

  • 第一阶段
  • 第二阶段
  • 第三阶段
  • 第四阶段

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲临床试验设备和辅助解决方案市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。临床试验设备和辅助解决方案市场的主要参与者包括 Ancillare, LP、Imperial CRS, Inc.、Woodley Equipment Company Ltd.、Thermo Fisher Scientific, Inc.、Parexel International (MA) Corporation、Emsere (MediCapital Rent)、Quipment SAS、IRM、Marken、Myonex、Yourway。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法论
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：临床试验设备及辅助解决方案 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按产品分類的市场吸引力分析
    • 按阶段分析市场吸引力
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：全球临床试验设备和辅助解决方案市场分析：按产品

  • 按产品概述
  • 历史和预测数据
  • 按产品分析
  • 采购（购买（设备、辅助设备）、租赁（设备、辅助设备））
  • 供应/物流（运输、包装、其他）
  • 服务（校准、设备维修、其他）
  • 其他的

第 6 章：全球临床试验设备和辅助解决方案市场分析：按阶段

  • 分阶段概览
  • 历史和预测数据
  • 按阶段分析
  • 第一阶段
  • 第二阶段
  • 第三阶段
  • 第四阶段

第 7 章：全球临床试验设备和辅助解决方案市场分析：按地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区国家/地区销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 8 章：临床试验设备与辅助解决方案公司的竞争格局

  • 临床试验设备及辅助解决方案市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 9 章：公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Ancillare
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • LP
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Imperial CRS Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Woodley Equipment Company Ltd.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Thermo Fisher Scientific Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Parexel International (MA) Corporation
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Emsere (MediCapital Rent)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Quipment SAS
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • IRM
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Marken
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Myonex
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Yourway
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展

注意 - 在公司概况中，财务详细资讯和近期发展视情况而定，或者如果是私人公司，则可能不包括在内

Product Code: VMR112113697

The global demand for Clinical Trial Equipment & Ancillary Solutions Market is presumed to reach the market size of nearly USD 7.02 Billion by 2032 from USD 3.1 Billion in 2023 with a CAGR of 9.5% under the study period 2024 - 2032.

Clinical trial equipment and ancillary solutions refer to the tools, devices, and support services utilized in medical research studies to collect data and conduct experiments. This encompasses a diverse range of equipment, from diagnostic devices to laboratory instruments, along with ancillary services such as data management, logistics, and regulatory compliance support. These resources are vital for ensuring the smooth and reliable execution of clinical trials in pharmaceutical and healthcare research.

MARKET DYNAMICS

The clinical trial equipment and ancillary solutions market is driven by factors such as the increasing number of clinical trials, advancements in medical research, and the rising prevalence of chronic diseases. The growing complexity of clinical trials necessitates a wide range of specialized equipment and ancillary services, including data management tools, logistics, and laboratory services. The emphasis on precision medicine and personalized therapies further boosts the demand for advanced clinical trial equipment. Regulatory support and initiatives to streamline the drug development process contribute to market growth. Additionally, the expansion of contract research organizations (CROs) and the globalization of clinical trials fuel the demand for comprehensive equipment and ancillary solutions, driving the overall market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of clinical trial equipment & ancillary solutions. The growth and trends of clinical trial equipment & ancillary solutions industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the clinical trial equipment & ancillary solutions market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Sourcing (Procurement (Equipment, Ancillaries), Rental (Equipment, Ancillaries))
  • Supply/Logistics (Transportation, Packaging, Others)
  • Service (Calibrations, Equipment Servicing, Others)
  • Others

By Phase

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Clinical Trial Equipment & Ancillary Solutions market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Clinical Trial Equipment & Ancillary Solutions market include Ancillare, LP, Imperial CRS, Inc., Woodley Equipment Company Ltd., Thermo Fisher Scientific, Inc., Parexel International (MA) Corporation, Emsere (MediCapital Rent), Quipment SAS, IRM, Marken, Myonex, Yourway. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Phase
    • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET ANALYSIS BY PRODUCT

  • 5.1 Overview by Product
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Product
  • 5.4 Sourcing (Procurement (Equipment, Ancillaries), Rental (Equipment, Ancillaries)) Historic and Forecast Sales by Regions
  • 5.5 Supply/Logistics (Transportation, Packaging, Others) Historic and Forecast Sales by Regions
  • 5.6 Service (Calibrations, Equipment Servicing, Others) Historic and Forecast Sales by Regions
  • 5.7 Others Historic and Forecast Sales by Regions

6 . GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET ANALYSIS BY PHASE

  • 6.1 Overview by Phase
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Phase
  • 6.4 Phase I Historic and Forecast Sales by Regions
  • 6.5 Phase II Historic and Forecast Sales by Regions
  • 6.6 Phase III Historic and Forecast Sales by Regions
  • 6.7 Phase IV Historic and Forecast Sales by Regions

7 . GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2. North America By Segment Sales Analysis
    • 7.3.3. North America By Country Sales Analysis
    • 7.3.4. United State Sales Analysis
    • 7.3.5. Canada Sales Analysis
    • 7.3.6. Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2. Europe by Segment Sales Analysis
    • 7.4.3. Europe by Country Sales Analysis
    • 7.4.4. United Kingdom Sales Analysis
    • 7.4.5. France Sales Analysis
    • 7.4.6. Germany Sales Analysis
    • 7.4.7. Italy Sales Analysis
    • 7.4.8. Russia Sales Analysis
    • 7.4.9. Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2. Asia Pacific by Segment Sales Analysis
    • 7.5.3. Asia Pacific by Country Sales Analysis
    • 7.5.4. China Sales Analysis
    • 7.5.5. India Sales Analysis
    • 7.5.6. Japan Sales Analysis
    • 7.5.7. South Korea Sales Analysis
    • 7.5.8. Australia Sales Analysis
    • 7.5.9. South East Asia Sales Analysis
    • 7.5.10. Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2. Latin America by Segment Sales Analysis
    • 7.6.3. Latin America by Country Sales Analysis
    • 7.6.4. Brazil Sales Analysis
    • 7.6.5. Argentina Sales Analysis
    • 7.6.6. Peru Sales Analysis
    • 7.6.7. Chile Sales Analysis
    • 7.6.8. Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2. Middle East & Africa by Segment Sales Analysis
    • 7.7.3. Middle East & Africa by Country Sales Analysis
    • 7.7.4. Saudi Arabia Sales Analysis
    • 7.7.5. UAE Sales Analysis
    • 7.7.6. Israel Sales Analysis
    • 7.7.7. South Africa Sales Analysis
    • 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS COMPANIES

  • 8.1. Clinical Trial Equipment & Ancillary Solutions Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9 . COMPANY PROFILES OF CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Ancillare
    • 9.3.1. Company Overview
    • 9.3.2. Company Revenue
    • 9.3.3. Products
    • 9.3.4. Recent Developments
  • 9.4. LP
    • 9.4.1. Company Overview
    • 9.4.2. Company Revenue
    • 9.4.3. Products
    • 9.4.4. Recent Developments
  • 9.5. Imperial CRS Inc.
    • 9.5.1. Company Overview
    • 9.5.2. Company Revenue
    • 9.5.3. Products
    • 9.5.4. Recent Developments
  • 9.6. Woodley Equipment Company Ltd.
    • 9.6.1. Company Overview
    • 9.6.2. Company Revenue
    • 9.6.3. Products
    • 9.6.4. Recent Developments
  • 9.7. Thermo Fisher Scientific Inc.
    • 9.7.1. Company Overview
    • 9.7.2. Company Revenue
    • 9.7.3. Products
    • 9.7.4. Recent Developments
  • 9.8. Parexel International (MA) Corporation
    • 9.8.1. Company Overview
    • 9.8.2. Company Revenue
    • 9.8.3. Products
    • 9.8.4. Recent Developments
  • 9.9. Emsere (MediCapital Rent)
    • 9.9.1. Company Overview
    • 9.9.2. Company Revenue
    • 9.9.3. Products
    • 9.9.4. Recent Developments
  • 9.10. Quipment SAS
    • 9.10.1. Company Overview
    • 9.10.2. Company Revenue
    • 9.10.3. Products
    • 9.10.4. Recent Developments
  • 9.11. IRM
    • 9.11.1. Company Overview
    • 9.11.2. Company Revenue
    • 9.11.3. Products
    • 9.11.4. Recent Developments
  • 9.12. Marken
    • 9.12.1. Company Overview
    • 9.12.2. Company Revenue
    • 9.12.3. Products
    • 9.12.4. Recent Developments
  • 9.13. Myonex
    • 9.13.1. Company Overview
    • 9.13.2. Company Revenue
    • 9.13.3. Products
    • 9.13.4. Recent Developments
  • 9.14. Yourway
    • 9.14.1. Company Overview
    • 9.14.2. Company Revenue
    • 9.14.3. Products
    • 9.14.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Product (USD MN)
  • Sourcing (Procurement (Equipment, Ancillaries), Rental (Equipment, Ancillaries)) Market Sales by Geography (USD MN)
  • Supply/Logistics (Transportation, Packaging, Others) Market Sales by Geography (USD MN)
  • Service (Calibrations, Equipment Servicing, Others) Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis Market by Phase (USD MN)
  • Phase I Market Sales by Geography (USD MN)
  • Phase II Market Sales by Geography (USD MN)
  • Phase III Market Sales by Geography (USD MN)
  • Phase IV Market Sales by Geography (USD MN)
  • Global Clinical Trial Equipment & Ancillary Solutions Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Clinical Trial Equipment & Ancillary Solutions Report
  • Market Research Process
  • Market Research Methodology
  • Global Clinical Trial Equipment & Ancillary Solutions Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product
  • Market Attractiveness Analysis by Phase
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product (USD MN)
  • Sourcing (Procurement (Equipment, Ancillaries), Rental (Equipment, Ancillaries)) Market Sales by Geography (USD MN)
  • Supply/Logistics (Transportation, Packaging, Others) Market Sales by Geography (USD MN)
  • Service (Calibrations, Equipment Servicing, Others) Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Phase (USD MN)
  • Phase I Market Sales by Geography (USD MN)
  • Phase II Market Sales by Geography (USD MN)
  • Phase III Market Sales by Geography (USD MN)
  • Phase IV Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Companies Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.